Laura Cetran

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 122 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

OCT and CMR for the Diagnosis of Patients Presenting With MINOCA and Suspected Epicardial Causes

Édouard Gerbaud, Fabien Arabucki, Hubert Nivet et al. · JACC. Cardiovascular imaging · 2020 · 99 citations · Full text

Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease

Gilles Rioufol, François Dérimay, François Roubille et al. · Journal of the American College of Cardiology · 2021 · 99 citations · Full text

Cardiovascular Disease, Fractional Flow Reserve, Guide Treatment +8

Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial

Birgitte Krogsgaard Andersen, Martin Sejr‐Hansen, Luc Maillard et al. · The Lancet · 2024 · 75 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Fractional Flow Reserve +8

Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

Jeffrey L. Carson, Maria M. Brooks, Bernard Chaitman et al. · American Heart Journal · 2022 · 35 citations · Full text

Myocardial Ischemia, Cardiovascular Disease, Clinical Trials +6